生命早期感染、抗生素与儿童及成年早期起病炎症性肠病风险:两项斯堪的纳维亚出生队列的汇总分析
基于ABIS(瑞典)和MoBa(挪威)两项人群出生队列共103,046名儿童、1,663,898人年随访,前瞻性问卷收集3岁前感染频率与抗生素使用,采用随机效应模型汇总队列特异性aHR。校正感染频率后,1岁内任一抗生素使用与IBD风险相关(汇总aHR=1.33,95%CI=1.01-1.76),青霉素每增加一疗程aHR=1.28(95%CI=1.02-1.60);1至<3岁非青霉素抗生素每增加一疗程与溃疡性结肠炎相关(aHR=1.95,95%CI=1.38-2.75)。结论认为生命早期抗生素使用是儿童及成年早期起病IBD的显著危险因素,独立于感染频率。
要点
- 校正感染频率后,1岁内任一抗生素使用与IBD风险相关(汇总aHR=1.33,95%CI=1.01-1.76)。
- 1岁内青霉素每增加一疗程与IBD风险相关(aHR=1.28,95%CI=1.02-1.60)。
- 1至<3岁非青霉素抗生素每增加一疗程与溃疡性结肠炎相关(aHR=1.95,95%CI=1.38-2.75)。
核心结论
- 生命早期抗生素使用是儿童及成年早期起病IBD的显著危险因素,独立于感染频率。
研究设计与样本
- 基于ABIS(瑞典)和MoBa(挪威)两项人群出生队列的汇总分析,随访儿童自出生(1997-2009年)至2021年。
- 共纳入103,046名儿童(ABIS 11,872名,MoBa 91,174名),贡献1,663,898人年随访。
- 前瞻性问卷识别3岁前感染频率(任一、胃肠道和呼吸道)与抗生素使用(任一、青霉素和非青霉素)。
- IBD诊断需国家健康登记处至少2条记录。
- 估计校正父母教育、吸烟和IBD的队列特异性风险比(aHR),采用随机效应模型汇总;抗生素分析校正感染频率。
主要发现
- 随访期间395名儿童诊断为IBD。
- 0至<1岁和1至<3岁任一感染频率每增加一次感染,IBD的汇总aHR分别为1.01(95%CI=0.96-1.07)和1.00(95%CI=0.99-1.01)。
- 校正感染后,1岁内任一抗生素使用与未使用相比,IBD汇总aHR=1.33(95%CI=1.01-1.76)。
- 1岁内每增加一疗程抗生素的aHR=1.17(95%CI=0.96-1.44),主要由青霉素驱动(每增加一疗程aHR=1.28,95%CI=1.02-1.60)。
- 1至<3岁抗生素与IBD或克罗恩病无关联,但非青霉素抗生素与溃疡性结肠炎相关(每增加一疗程aHR=1.95,95%CI=1.38-2.75)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Childhood antibiotic use has been associated with inflammatory bowel disease (IBD), although the potential contribution of infection frequency remains uncertain. AIMS: To explore the association between early-life infections, antibiotics and IBD development. METHODS: We used population-based data from ABIS (Sweden) and MoBa (Norway) cohorts following children from birth (1997-2009) until 2021. Prospectively collected questionnaires identified infection frequency (any, gastrointestinal and respiratory) and antibiotics (any, penicillin and non-penicillin) until age 3. IBD diagnosis required ≥ 2 records in national health registries. Cohort-specific hazard ratios (aHR), adjusted for parental education, smoking and IBD were estimated and pooled using a random-effects model. Antibiotic analyses were adjusted for infection frequency. RESULTS: There were 103,046 children (11,872 ABIS and 91,174 MoBa), contributing to 1,663,898 person-years of follow-up, during which 395 were diagnosed with IBD. The frequency of any infection at 0 to < 1 and 1 to < 3 years showed a pooled aHR of 1.01 (95% confidence interval [CI] = 0.96-1.07) and 1.00 (95% CI = 0.99-1.01) per additional infection for IBD. Adjusting for infections, any versus no antibiotics in the first year was associated with IBD (pooled aHR = 1.33 [95% CI = 1.01-1.76]). The aHR for additional antibiotic course was 1.17 (95% CI = 0.96-1.44), driven by penicillin (per additional course, aHR = 1.28 [95% CI = 1.02-1.60]). Although antibiotics at 1 to < 3 years did not show an association with IBD or Crohn's disease, non-penicillin antibiotics were associated with ulcerative colitis (per additional course, aHR = 1.95 [95% CI = 1.38-2.75]). CONCLUSION: Early-life antibiotic use was, a significant risk factor for childhood and early adult-onset IBD, independent of infection frequency.
引用
- Mårild K, Lerchova T, Östensson M, et al. Early-Life Infections, Antibiotics and Later Risk of Childhood and Early Adult-Onset Inflammatory Bowel Disease: Pooled Analysis of Two Scandinavian Birth Cohorts. Aliment Pharmacol Ther. 2024. PMID: 39450871. doi:10.1111/apt.18358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。